Cell cycle quiescence is a critical feature contributing to haematopoietic stem cell (HSC) maintenance. Although various candidate stromal cells have been identified as potential HSC niches, the spatial localization of quiescent HSCs in the bone marrow remains unclear. Here, using a novel approach that combines whole-mount confocal immunofluorescence imaging techniques and computational modelling to analyse significant three-dimensional associations in the mouse bone marrow among vascular structures, stromal cells and HSCs, we show that quiescent HSCs associate specifically with small arterioles that are preferentially found in endosteal bone marrow. These arterioles are ensheathed exclusively by rare NG2 (also known as CSPG4) 1 pericytes, distinct from sinusoid-associated leptin receptor (LEPR) 1 cells. Pharmacological or genetic activation of the HSC cell cycle alters the distribution of HSCs from NG2 1 periarteriolar niches to LEPR 1 perisinusoidal niches. Conditional depletion of NG2 1 cells induces HSC cycling and reduces functional long-term repopulating HSCs in the bone marrow. These results thus indicate that arteriolar niches are indispensable for maintaining HSC quiescence.
Cell cycle quiescence is a critical feature contributing to haematopoietic stem cell (HSC) maintenance. Although various candidate stromal cells have been identified as potential HSC niches, the spatial localization of quiescent HSCs in the bone marrow remains unclear. Here, using a novel approach that combines whole-mount confocal immunofluorescence imaging techniques and computational modelling to analyse significant three-dimensional associations in the mouse bone marrow among vascular structures, stromal cells and HSCs, we show that quiescent HSCs associate specifically with small arterioles that are preferentially found in endosteal bone marrow. These arterioles are ensheathed exclusively by rare NG2 (also known as CSPG4) 1 pericytes, distinct from sinusoid-associated leptin receptor (LEPR) 1 cells. Pharmacological or genetic activation of the HSC cell cycle alters the distribution of HSCs from NG2 1 periarteriolar niches to LEPR 1 perisinusoidal niches. Conditional depletion of NG2 1 cells induces HSC cycling and reduces functional long-term repopulating HSCs in the bone marrow. These results thus indicate that arteriolar niches are indispensable for maintaining HSC quiescence.
Somatic stem cells self-renew to maintain tissue homeostasis for the lifetime of organisms through tightly controlled proliferation and differentiation [1] [2] [3] . In the bone marrow, recent studies have highlighted the critical influence of the microenvironment in regulating HSCs 4 . Deletion of genes involved in maintaining cell cycle quiescence has shown that unchecked HSC proliferation often leads to stem cell exhaustion [5] [6] [7] [8] . Although most HSCs are quiescent under homeostasis 9 , they can undergo activation, for example by interferon-mediated signals 7, 10, 11 . This raises the question of whether quiescent and proliferative HSCs are found in the same niche.
The identification of cellular constituents of the HSC niche has recently been the subject of intense study. Initial reports have suggested that osteoblasts are niche cells as HSCs tend to localize near endosteal surfaces 12 , and that factors increasing osteoblast numbers can also increase the number of HSCs 12, 13 . N-cadherin 1 osteoblasts have been proposed to promote HSC quiescence through direct contact 12, 14 and secretion of angiopoietin 1 (ref. 15) or osteopontin 16, 17 . However, the synthesis of these factors is not specific to osteoblasts, and other studies have found that most bone marrow HSCs are found near sinusoidal endothelial cells 18 and perivascular stromal cells including CXCL12abundant reticular cells 19, 20 , Nestin 1 mesenchymal stem cells 21 or LEPR 1 cells 22 . On the basis of these data, a prevalent unifying interpretation of the literature has been that the osteoblastic and vascular niches confer distinct microenvironments promoting quiescence and proliferation, respectively 2, 23 . However, this popular concept has not been supported by rigorous analyses. To evaluate this issue, we have used novel three-dimensional bone marrow imaging combined with computational modelling to assess meaningful relationships between endogenous quiescent HSCs and stromal structures. These studies have allowed us to identify distinct vascular niches mediating stem cell quiescence and proliferation.
HSCs associate with bone marrow arterioles
To gain detailed insight into the three-dimensional structure of the HSC niche, we prepared whole-mount tissues to visualize by confocal immunofluorescence imaging the architecture of long-bone and sternal marrow over ,75 mm thickness (Fig. 1a, b and Extended Data Fig. 1a, b ). To specifically label bone marrow endothelial cells, we performed in vivo staining (Extended Data Fig. 1c-e ). Whole-mount assessment of the femoral bone marrow vasculature revealed an even distribution of the sinusoidal network that occupies 30 6 5% of the bone marrow volume ( Fig. 1c, d) and where individual sinusoidal vessels are regularly spaced by 46 6 1 mm (Extended Data Fig. 1f ). In addition to the sinusoidal network, three-dimensional visualization of the bone marrow vasculature highlighted the presence of small-calibre (10-20 mm) Sca-1 (stem cell antigen-1) hi VEGFR2 (also known as KDR or FLK1) 1 VEGFR3 (also known as FLT4) 2 arterioles 24 , which were found predominantly in close proximity to the bone 25 and comprised a much smaller volumetric fraction, 1.2 6 0.1% of the bone marrow ( Fig. 1a-d and Extended Data Fig. 2a, b) . The vessels were confirmed as bona fide arterioles by their pronounced TIE2 (also known as TEK)-green fluorescent protein (GFP) expression 26 , absence of in vivo staining with the sinusoid-specific Dil-labelled acetylated low-density lipoprotein (Dil-Ac-LDL) 26 , and strong staining with the artery-specific dye Alexa Fluor 633 (ref. 27) ( Fig. 1e and Extended Data Fig. 2b-f ). The distribution of phenotypic CD150 1 CD48 2 CD41 2 Lineage 2 HSCs 18 was not uniform as they localized predominantly to the peripheral zone rather than in close proximity to the central vein in the long-bone bone marrow ( Fig. 1d and Extended Data Fig. 3a ). We validated the identification of rare phenotypic HSCs by using whole-mount preparations of the mouse sternum 28 . Unlike long bones, which are mostly occupied by adipocytes in adult humans 29 , the sternum exhibits rich haematopoietic activity in both species. The mouse sternum is made of six thin bone compartments in which all HSCs can be enumerated ( Fig. 1f and Extended Data Fig. 3b , c).
The absolute numbers of HSCs per sternal bone compartment, determined by whole-mount imaging, was similar to assessment by fluorescence-activated cell sorting (FACS), indicating that the staining of endogenous HSCs was reliable (Extended Data Fig. 3d ). We next examined the spatial relationships between individual HSCs and arterioles and sinusoids by whole-mount immunostaining of sternal bone marrow. We found that 36.8 6 1.8% and 67.1 6 3.5% of HSCs were located within 20-mm distance from arterioles and sinusoids, and 14.9 6 2.5% and 32.9 6 5.2% were adjacent to those vessels, respectively (Fig. 1g , h and Extended Data Fig. 3e , f). The high proportion of HSCs near sinusoids is consistent with previous reports 18, 19 .
As the bone marrow sinusoidal network was dense and appeared to be regularly interspaced, we evaluated in more detail whether the spatial distribution of HSCs was independent of the sinusoidal network or significantly biased in relation to a putative sinusoidal niche. To address this issue, we developed a computational simulation to assess the statistical relevance of these associations (Extended Data Fig. 4a -c). We carried out 1,000 simulations in which 20 HSCs were randomly positioned on images of whole-mount-prepared sterna. We found that the mean distance observed in situ to sinusoids could not be statistically differentiated from that of randomly placed HSCs (14.2 mm and 14.8 mm for random and observed, respectively; Fig. 1i ).
By contrast, the observed mean distance to arterioles (52.0 mm) was highly statistically different from that of randomly placed HSCs (78.3 mm, P 5 0.012; Fig. 1i ). Thus, these data suggest that associations between HSCs and arterioles are highly significant whereas the close relationship observed with sinusoids could not be discriminated from that of a random distribution.
Distinct Nestin 1 cells segregate with distinct vessels
Nestin 1 perivascular cells have been identified as HSC niche cells containing all bone marrow mesenchymal stem cell activity 21 . Detailed three-dimensional imaging and FACS analyses revealed two distinct types of Nestin-GFP (hereafter Nes-GFP) 1 cells in the bone marrow on the basis of their GFP expression levels and cellular morphology ( Fig. 2a, b and Extended Data Fig. 5a ). Nes-GFP bright cells were much rarer (,0.002% of bone marrow) than Nes-GFP dim cells ( Fig. 2a and Extended Data Fig. 5b ), and found exclusively along arterioles in both sternal and long-bone bone marrow (Extended Data Figs 2d, e and 5c-h). Consistent with this observation, similar HSC distribution patterns were obtained when plotting distances from arterioles or from Nes-GFP bright cells (hereafter referred to as periarteriolar Nestin cells, Nes peri ; Fig. 1g , h and Extended Data Fig. 3e , f, P 5 0.97). The more abundant Nes-GFP dim population was reticular in shape (hereafter referred to as Nes retic cells) and was largely associated with sinusoids ( Fig. 2b and Extended Data Figs 3e, f and 5g). Nes peri cells, but not 
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Nes retic cells, were decorated with tyrosine hydroxylase 1 sympathetic nerves and glial fibrillary acidic protein 1 Schwann cells, which have been reported to modulate HSC behaviour in the bone marrow [30] [31] [32] ( Fig. 2c and Extended Data Fig. 5i ). Although both Nestin 1 cell subsets accounted for the mesenchymal progenitor activity (fibroblastic colonyforming units; CFU-F) in bone marrow, most CFU-F were contained in Nes peri cells (Extended Data Fig. 5j ). To get additional insight into potential differences between these two stromal subsets, we subjected Nes peri and Nes retic cells to RNA sequencing (RNA-seq) analyses. Comparison of the whole-genome transcriptome revealed differential enrichment of several molecular pathways and functional clusters, including HSC niche, cytokine-receptor interactions, DNA replication and cell cycle ( Fig. 2d , e and Supplementary Table 1 ). Indeed, Nes peri cells showed significantly higher expression of genes associated with the HSC niche ( Fig. 2d , e and Extended Data Fig. 5k ). In addition, expression of genes in two pathways, DNA replication and cell cycle, was significantly enriched in Nes retic cells ( Fig. 2d, e ), suggesting that the two subsets had differing cell cycle characteristics.
Arteriolar Nes peri niche cells are quiescent
On the basis of these results, we evaluated in more detail the cell cycle status of bone marrow stromal cells, and more specifically of Nes retic and Nes peri cells. Expression of the nuclear proliferation markers Ki-67 and proliferation cell nuclear antigen (PCNA) in Nes peri cells was significantly lower than in Nes retic cells and CD45 2 Ter119 2 CD31 2 Nes-GFP 2 stromal cells ( Fig. 3a, b ), which was confirmed by FACS analysis (Fig. 3c, d) . To test the relevance of niche cell quiescence, we challenged mice with 5-fluorouracil (5-FU), a drug that kills cycling cells. After 5-FU administration, Nes peri cells were largely preserved structurally and numerically compared to Nes retic cells ( Fig. 3e -g), confirming their quiescent state.
Dormant HSCs associate with arterioles
We proposed that the arteriolar quiescent niche cells may themselves harbour quiescent HSCs. Consistent with previous studies 10, 33 , we found that most HSCs were not actively cycling, but ,20% of HSCs were in the non-quiescent G1 phase of the cell cycle (Extended Data Fig. 6a ). Prolonged quiescence has been referred to as dormancy and tracked as label-retaining cells 10 . We first evaluated the spatial associations of dormant HSCs with Nes peri cells by label-retaining cell pulse-chase experiments with 5-ethynyl-29-deoxyuridine (EdU) in the long-bone bone marrow. Significantly more EdU 1 CD150 1 CD48 2 CD41 2 Lineage 2 HSCs compared to total HSCs were located within a 20-mm distance from Nes peri cells (Fig. 4a, b and Extended Data Fig. 6b ; 65.8 6 0.8% versus 44.3 6 1.8%, P 5 0.016). We next analysed the cell cycle status and distribution of HSCs in relation to arterioles with Ki-67 staining in the sternal bone marrow and found that a significantly higher proportion of Ki-67 2 quiescent HSCs were located within a 20-mm distance compared to Ki-67 1 non-quiescent HSCs (Fig. 4c, d , g and Extended Data Fig. 6c, d ). There was no significant difference in the proportions of adjacent cells between quiescent and non-quiescent HSCs (Extended Data Fig. 6b, c) , suggesting that proximity to arterioles, rather than direct contact, promotes HSC quiescence. As osteoblasts have been suggested to be associated with quiescent HSCs 12,14-17 , we evaluated the distribution of HSCs in relation to osteoblasts in the sternal bone marrow using transgenic 
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mice expressing GFP under a 2.3-kilobase fragment of the collagen promoter (Col2.3-GFP), in which osteoblasts and osteocytes express GFP 34 . We found that 20.7 6 1.9% of total HSCs were located within 20-mm distance from Col2.3-GFP 1 cells ( Fig. 4e and Extended Data Fig. 6e ). We performed the computational simulation with Col2.3-GFP 1 cells and found that in contrast to arterioles, HSCs were not significantly associated with Col2.3-GFP 1 cells (Extended Data Fig. 6f ). Moreover, there was no significant difference in the distribution of quiescent and non-quiescent HSCs in relation to Col2.3-GFP 1 cells in the sternal bone marrow (Fig. 4f , g and Extended Data Fig. 6g , P 5 0.93). These results suggest that quiescent HSCs are preferentially associated with arterioles in both long-bone and sternal marrow.
To test this idea using functional assays, we evaluated HSC-arteriole associations in mice treated with 5-FU. We found that at nadir on days 3 and 7, the vast majority of HSCs were closely associated with Nes peri cells (control/day 3/day 7; 34.4 6 1.0/71.1 6 3.9/70.6 6 4.0% in 0-20 mm, respectively) and that HSCs expanded in further distance from Nes peri cells upon recovery in the sternal bone marrow ( Fig. 4h and Extended Data Fig. 6h, i) . These data indicate that arterioles indeed provide a milieu promoting quiescence for both HSCs and their niche cells, and a safe harbour to protect them against genotoxic insults.
We next tested whether changes in HSC cycling would lead to altered distribution. To this end, we injected mice with polyinosinicpolycytidylic acid (Poly(I:C)), a compound reported to induce proliferation of HSCs via interferon-a production, which can lead to HSC exhaustion 7, 8 . Poly(I:C) treatment increased the fraction of non-quiescent HSCs (Extended Data Fig. 7a ) and altered their distribution in relation to arterioles in that the percentage of HSCs within 20 mm was significantly reduced compared to phosphate-buffered saline-treated animals in the sternal bone marrow (Extended Data Fig. 7b , P 5 0.007). Furthermore, we evaluated a genetic mouse model deficient in promyelocytic leukaemia protein (Pml 2/2 ) that was shown to compromise HSC quiescence in a cell-autonomous manner and caused HSC exhaustion 6 .
Remarkably, endogenous HSCs were distributed significantly further away from arterioles in Pml 2/2 mice compared to wild-type animals (Extended Data Fig. 7c , P 5 1.9 3 10 26 ). Notably, the location of quiescent Ki-67 2 cells was markedly affected (Extended Data Fig. 7d, e ). These data suggest the possibility that there are spatially distinct niches for quiescent and proliferating HSCs in the bone marrow.
To further confirm this notion, we treated mice with granulocyte colony-stimulating factor (G-CSF), a drug commonly used to mobilize HSCs from the bone marrow to the circulation, and that is also known to induce HSC proliferation 35, 36 . Short-term (1 or 2 days) administration of G-CSF led to altered HSC distribution further away from Nes peri cells. By contrast, further treatment (4 days) led to expansion of HSCs around Nes peri cells (Extended Data Fig. 7f, g) . In line with these data, G-CSF also downregulated HSC retention factors such as CXCL12 in the Nestin 1 niche cells 21 , which also may contribute to the shift from the quiescent to the proliferative (mobilizable) niches at early phase, the release of the mobilizable pool, and HSC replenishment at late phase. This model further highlights the importance of local cues in fine-tuning HSC behaviour in the bone marrow.
NG2 1 arteriolar niche cells promote HSC quiescence LEPR 1 perivascular cells have been reported to represent an important source of stem cell factor (SCF) required for the maintenance of HSCs in the bone marrow 22 . As Nestin 1 cells were shown to express large amounts of SCF 21 , we evaluated the overlap between Nes peri or Nes retic cells and LEPR 1 cells. Using triple-transgenic Lepr-cre/loxp-tdTomato/Nes-GFP mice, we found that LEPR 1 cells were adjacent to sinusoids in a manner similar to Nes retic cells (Extended Data Fig. 8a) . Indeed, Nes retic cells largely overlapped (,80%) with LEPR 1 cells whereas we found no overlap between Nes peri and LEPR 1 cells (Extended Data Fig. 8b, c) . By contrast, Nes peri , but not Nes retic , cells were positive for the classical pericyte marker NG2 and a-smooth muscle actin 37 (Extended Data Fig. 9a-f RESEARCH ARTICLE cells, we generated triple-transgenic mice to label both NG2 1 and Nestin 1 cells (NG2 promoter/enhancer driving tamoxifen-inducible Cre; NG2-cre ERTM /loxp-tdTomato/Nes-GFP mice). In these mice, 30% of Nes peri cells were labelled by the NG2-cre ERTM transgene (Fig. 5a, b and Extended Data Fig. 9g, h) , a recombination efficiency consistent with that reported for oligodendrocyte progenitors in the brain 38 . Notably, no labelling was observed in Nes retic cells or in other stromal cells ( Fig. 5b and Extended Data Fig. 9i ).
To examine the function of NG2 1 Nes peri cells in HSC maintenance, we intercrossed NG2-cre ERTM with an inducible diphtheria toxin receptor (iDTR) line. Tamoxifen and diphtheria toxin treatment depleted ,55% of Nes peri cells without significantly affecting the vascular volume as determined by whole-mount imaging 7-16 days after diphtheria toxin administration ( Fig. 5c and Extended Data Fig. 10a-c ). NG2 1 cell depletion also did not affect the expression of HSC niche genes in endothelial cells (Extended Data Fig. 10d, e ). However, depletion of NG2 1 cells altered HSC localization away from arterioles ( Fig. 5d and Extended Data Fig. 10f ) and switched them into non-quiescent status (Fig. 5e, f) . In addition, we found that the number and frequency of HSCs in the bone marrow and spleen, as determined phenotypically (Fig. 5g and Extended Data Fig. 10g ) and functionally using long-term culture-initiating cell (LTC-IC; Extended Data Fig. 10h, i) or competitive reconstitution assays (Fig. 5h) , were significantly reduced 16 days after diphtheria toxin administration. These results indicate that depletion of NG2 1 cells reduces the HSC pool rather than inducing mobilization to extramedullary sites (Extended Data Fig. 10j ). Taken together, these data strongly suggest that rare NG2 1 periarteriolar cells promote HSC quiescence and are essential for HSC maintenance in the bone marrow.
Discussion
Here, we show that arterioles organize a critical niche that maintains HSC quiescence in the bone marrow. Arterioles are associated with both quiescent NG2 1 niche cells and HSCs, suggesting that the vessel itself may be a critical gatekeeper of stem cell quiescence in the bone marrow. Arterioles are structurally distinct from sinusoids as they are surrounded by sympathetic nerves, layers of smooth muscle cells and matrix components to carry blood from the heart under high pressure (Supplementary Table 2 ). These differing characteristics translate into significant differences in the transcriptional program of arteriolar and venular endothelial cells 39 . Likewise, arteriolar Nes peri cells and sinusoidal Nes retic cells can be distinguished by their individual transcriptional profiles reflecting relative enrichments in cell cycle quiescence and HSC-niche-related genes in Nes peri cells. The present data show that upon severe genotoxic insult, the mitotically active Nes retic sinusoidal niche cells are largely destroyed, whereas the quiescent Nes peri arteriolar niche cells are chemoresistant. The association and quiescence of both haematopoietic and mesenchymal stem cells at this site may thus endow arterioles with the potential for orchestrating haematopoietic and stromal regeneration 40 .
Given the recent studies showing that CXCL12 derived from mesenchymal progenitors marked by Prx1-cre contributes to HSC maintenance 41, 42 , it is possible that NG2 1 Nes peri cells are also targeted by Prx1-cre. Although Nes-GFP 1 cells express high levels of SCF 21 , Nes-cre mediated deletion of Scf has no effect on HSC function 22 . This may be due to the low recombination efficiencies among Nes-GFP 1 cells in this model, allowing for compensation by the non-targeted cells. In keeping with the notion that multiple niche constituents exert distinct functions, conditional deletion of Cxcl12 by Lepr-cre 
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does not affect HSC numbers in the bone marrow, but induces their mobilization 42 . The idea that sinusoids may represent a proliferative niche is consistent with recent studies indicating that E-selectin, an adhesion molecule constitutively expressed in certain bone marrow sinusoidal microdomains 43 , promotes HSC proliferation and blockade of E-selectin protects HSCs following chemotherapy or c-irradiation 44 . It is therefore conceivable that a continuous exchange between the sinusoidal and arteriolar niches contributes to maintain a tightly controlled balance of the HSC pool between proliferation and dormancy.
An arteriolar niche maintaining stem cell dormancy has the potential to protect haematopoietic malignancies and metastatic cancer stem cells. Gaining knowledge of the reciprocal regulation and functional correlation of these niches will thus have important implications in understanding stem cell fate in health and cancer.
METHODS SUMMARY
B6.Cg-Tg(Cspg4-cre/Esr1*)BAkik/J, STOCK Tg (TIE2GFP) 287Sato/J (TIE2-GFP) mice, C57BL/6-Gt(ROSA)26 Sortm1(HBEGF) Awai/J, B6.Cg-Gt(ROSA) 26Sortm14(CAG-tdTomato)Hze/J, B6.129-Leprtm2(cre)Rck/J (Lepr-Cre), Pml 2/2 , Nes-GFP 45 and Col2.3-GFP 34 mice were used in this study. Unless indicated otherwise, data are presented as mean 6 s.e.m.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. RESEARCH ARTICLE METHODS Animals. B6.Cg-Tg(Cspg4-cre/Esr1*)BAkik/J, STOCK Tg(TIE2GFP) 287Sato/J (TIE2-GFP), C57BL/6-Gt(ROSA)26 Sortm1(HBEGF) Awai/J, B6.Cg-Gt(ROSA) 26Sortm14(CAG-tdTomato)Hze/J and B6.129-Leprtm2(cre)Rck/J (Lepr-Cre) mice (all from Jackson Laboratory), C57BL/6-CD45.1/2 congenic strains (from the National Cancer Institute), Pml 2/2 mice (gift from P.P. Pandolfi) and Nes-GFP mice 45 were bred in our facilities. Col2.3-GFP mice were a gift from D. W. Rowe. All mice were maintained on the C57BL/6J background. Unless indicated otherwise, 7-12-week-old male and female mice were used. No randomization or blinding was used to allocate experimental groups. All experimental procedures were approved by the Animal Care and Use Committees of Albert Einstein College of Medicine.
Immunofluorescence imaging. In vivo staining of bone marrow endothelial cells: to specifically stain endothelial cells, fluorescently conjugated antibodies (2 mg per mouse), Alexa Fluor 633 (50 mg per mouse) or Dil-Ac-LDL (1 mg g 21 ) were intravenously injected. Mice were perfused with PBS, 10 min (for antibodies) or 4 h (for Alexa Fluor 633 and Dil-Ac-LDL) after injection to remove unbound reagents. Sterna and long bones were collected for FACS or immunofluorescence imaging.
Preparations of whole-mount tissues and frozen sections of long bones: femoral or tibial bones were perfusion-fixed and then post-fixed for 30 min in 4% paraformaldehyde (PFA), incubated in 15% and 30% sucrose for cryoprotection and embedded in optical cutting temperature compound (OCT) (Tissue-Tek) at 220 uC. For whole-mount staining, bones were shaved on a cryostat until the bone marrow cavity was fully exposed. Bones were carefully harvested from melting OCT. Frozen sections were prepared according to the Kawamoto method 46 .
Whole-mount tissue preparation of the sternum: sternal bones were collected and transected with a surgical blade into 2-3 fragments. The fragments were bisected sagittally for the bone marrow cavity to be exposed, fixed in 4% PFA.
Immunofluorescence staining of whole-mount tissues and frozen sections of the sterna and long bones: whole-mount tissues and sections were blocked/ permeabilized in PBS containing 20% normal goat serum and 0.5% Triton X-100, and stained with primary antibodies for 1-3 days. The tissues were incubated with secondary antibodies for 2 h. Images were acquired using a ZEISS AXIO examiner D1 microscope (Zeiss) with a confocal scanner unit, CSUX1CU (Yokogawa), and reconstructed in three dimensions with Slide Book software (Intelligent Imaging Innovations) or Volocity software (PerkinElmer).
High-speed multichannel fluorescence intravital microscopy (MFIM): we performed MFIM of the calvarial bone marrow as described previously 47 . Bone marrow sinusoids and arterioles were visualized by administration of 10 mg of Rhodamine 6G (R6G) and 50 mg of Alexa Fluor 633, respectively. Cell sorting and flow cytometry. For sorting of Nes peri and Nes retic cells, bone marrow cells from 3-5 mice were pooled for a single experiment. Bone marrow cells were flushed and digested with 1 mg ml 21 collagenase IV (Sigma) and 2 mg ml 21 dispase (Gibco) in Hank's balanced salt solution (Gibco) for 45 min at 37 uC. All cell-sorting experiments were performed using an Aria Cell Sorter (BD Biosciences). Flow cytometric analyses were carried out using an LSRII flow cytometer equipped with FACS Diva 6.1 software (all BD Biosciences). Dead cells and debris were excluded by FCS, SSC and DAPI (4',6-diamino-2-phenylindole) (Sigma) staining profiles. Data were analysed with FlowJo (Tree Star) or FACS Diva 6.1 software. Antibodies and staining reagents. RNA isolation and quantitative PCR. Bone marrow cells were collected from Nes-GFP mice and Nes peri and Nes retic cells were sorted according to their specific flow cytometric profiles. Messenger RNA was purified with polyT-conjugated Dynabeads (Invitrogen) and conventional reverse transcription, using the Sprint PowerScript reverse transcriptase (Clontech), was performed in accordance with the manufacturer's protocol. Quantitative PCR was performed with SYBR Green (Roche) on an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems). A primer concentration of 300 nM was found to be optimal in all cases. The sequences of the oligonucleotides used are included in Supplementary Table 3 .
The PCR protocol consisted of one cycle at 95 uC (10 min) followed by 40 cycles of 95 uC (15 s) and 60 uC (1 min). Expression of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was used as a control. The average threshold cycle number (Ct) for each tested mRNA was used to quantify the relative expression of each gene; 2 -(Ct(gene) -Ct(control)) . RNA preparation and next-generation sequencing. Total RNA from sorted Nes peri and Nes retic cells was extracted using the RNAqueous kit (Life Technologies) and concentrated using RNA Clean and Concentrator columns (Zymo Research Corporation). The integrity and purity of total RNA were assessed using an Agilent Bioanalyzer and OD260/280. Complementary DNA was generated using a Clontech SMARTer Ultra Low RNA kit for Illumina Sequencing (Clontech Laboratories) from 100 pg-1 ng of total RNA. cDNA was fragmented using Covaris (Covaris Inc.), profiled using an Agilent Bioanalyzer, and subjected to Illumina library preparation using NEBNext reagents (New England Biolabs). The quality and quantity and the size distribution of the Illumina libraries were determined by an Agilent Bioanalyzer 2100. The libraries were then submitted for Illumina HiSeq2000 sequencing according to the standard operation procedure. Paired-end 90-or 100-nucleotide reads were generated and checked for data quality using FASTQC (Babraham Institute) and subjected to data analysis using the platform provided by DNAnexus (DNAnexus). For sorting of Nes peri and Nes retic cells, bone marrow cells from 5-7 mice were pooled to get a single biological sample. Triplicate biological samples per population from three independent sortings were processed for RNA-seq. RNA-seq data analysis. Pre-processing of the RNA-seq reads was performed by Otogenetic corp. The RNA-seq reads were aligned using TopHat (version 1.3.3) and levels of gene expression were quantified using Cufflinks (version 1.3.0). Genes that did not pass the quantification status flagged by Cufflinks in either Nes retic or Nes peri cell populations were excluded from the analysis. The quantification status represents the success of the Cufflinks algorithm in quantifying expression from the RNA-seq reads that were mapped for a gene. Using Bioconductor, genes were mapped to their Entrez Gene identifiers using the org.Mm.eg.db (version 2.5.0) package and to corresponding pathways based on definitions provided by the Kyoto Encyclopedia of Genes and Genomes (KEGG) via the KEGG.db (version 2.5.0) annotation package. The expression data was transformed by applying a log 2 -transformation to the ratio of (1 1 Nes peri FPKM values) to (1 1 Nes retic FPKM values) where the constant value of 1 was added because of the frequency of zero values observed in raw data. Log fold change of Nes peri /Nes retic expression was calculated for pathways defined by the KEGG orthology system (http://www.genome.jp/kegg-bin/get_htext?ko00001.keg) and using the HSC niche gene set defined by previous microarray studies 21, 22 . Pathway enrichment of genes showing differential expression between Nes peri and Nes retic cells was assessed using a Kolmogorov-Smirnov test. P values were adjusted for multiple testing using the Benjamini-Hochberg method which controls the false discovery rate. EdU treatment and label-retaining assay. In vivo EdU (Invitrogen) labelling was performed as previously described with BrdU 10 . In brief, Nes-GFP mice were pulsed with 1 mg of EdU for 14 days followed by an EdU-free chase period of 90 days. Long bones were collected and prepared for immunostaining. The frozen bone marrow sections were stained with a Click-iT EdU Imaging Kit (Invitrogen) according to the manufacturer's instructions. Cell cycle analysis. Cell cycle analysis was performed as described previously 10 . In brief, bone marrow cells were stained with surface markers, fixed in 2% PFA in PBS, washed, permeabilized with 0.1% Triton X-100 in PBS, and stained with anti-Ki67 antibody and Hoechst 33342 at 20 mg ml 21 for 30 min. After washing, cells were analysed by LSRII Flow Cytometer (Becton Dickinson). CFU-F assay. Sorted cells (1-3 3 10 2 ) were seeded per well in a 12-well adherent tissue culture plate using Phenol Red free a-MEM (Gibco) supplemented with 20% FBS (Hyclone), 10% MesenCult stimulatory supplement (StemCell Technologies) and 0.5% penicillin-streptomycin. Half of the media was replaced after 7 days and at day 14. Cells were stained with Giemsa staining solution (EMD Chemicals). In vivo treatments. Poly(I:C) (5 mg kg 21 ) was injected intraperitoneally every other day (two doses). Mice were analysed 24 h after the last injection. 5FU (250 mg kg 21 ) was injected intravenously, and mice were analysed accordingly. For haematopoietic stem/progenitor cells mobilization, mice received two (day 1), four (day 2) or eight (day 4) consecutive injections of filgrastim (Amgen) (125 mg kg 21 twice a day subcutaneously) or saline. Induction of Cre ERTM -mediated recombination and iDTR-mediated cell depletion. Male mice older than 8 weeks were injected with 1 mg tamoxifen (Sigma) twice a day for five consecutive days as described previously 38 . For diphtheria toxin-mediated cell depletion, 100 mg kg 21 of diphtheria toxin (Sigma) were injected intraperitoneally 2 days after the last tamoxifen injection.
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LTC-IC assay. To determine LTC-IC numbers, serial dilutions of bone marrow mononuclear cells were plated on single-well stromal cultures; 4 weeks later each individual well was assayed for the presence of CFU-C as described 48 . Bone marrow HSC frequencies were estimated by the Newton-Raphson method of maximum likelihood and Poisson statistics as the reciprocal of the number of test cells that yielded a 37% negative response. LTC-IC frequencies and statistical significance were determined by using the ELDA software (http://bioinf.wehi. edu.au/software/elda/). Competitive reconstitution. Competitive repopulation assays were performed using the CD45.1/CD45.2 congenic system. Equivalent volumes of bone marrow cells collected from NG2-cre ERTM /iDTR or Control mice (CD45.2) were transplanted into lethally irradiated (12 Gy) CD45.1 recipients with 0.3 3 10 6 competitor CD45.1 cells. CD45.1/CD45.2 chimaerism of recipients' blood was analysed up to 4 months after transplantation.
Computational modelling of HSC localization. Refer to Extended Data Fig. 4 . The computational simulation was performed with MATLAB software. Statistics. All data are represented as mean 6 s.e.m. Comparisons between two samples were done using the unpaired Student's t tests. One-way ANOVA analyses followed by Tukey's multiple comparison tests were used for multiple group comparisons. Two-sample Kolmogorov-Smirnov tests were used for comparisons of distribution patterns. Statistical analyses were performed with GraphPad Prism 6 or MATLAB software. *P , 0.05, **P , 0.01, ***P , 0.001. 
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